![Leading Consumer Healthcare Products - Pfizer 2014 Annual Review | Pfizer: the world's largest research-based pharmaceutical company Leading Consumer Healthcare Products - Pfizer 2014 Annual Review | Pfizer: the world's largest research-based pharmaceutical company](https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2014/assets/images/science/products/nexium-2.jpg)
Leading Consumer Healthcare Products - Pfizer 2014 Annual Review | Pfizer: the world's largest research-based pharmaceutical company
![Leading Consumer Healthcare Products - Pfizer 2012 Annual Review | Pfizer: the world's largest research-based pharmaceutical company Leading Consumer Healthcare Products - Pfizer 2012 Annual Review | Pfizer: the world's largest research-based pharmaceutical company](https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2012/images/img-90.png)
Leading Consumer Healthcare Products - Pfizer 2012 Annual Review | Pfizer: the world's largest research-based pharmaceutical company
![Pfizer: New CEO, New Strategy, New Focus On Brand Name Drugs In A Year Of Drastic Change (NYSE:PFE) | Seeking Alpha Pfizer: New CEO, New Strategy, New Focus On Brand Name Drugs In A Year Of Drastic Change (NYSE:PFE) | Seeking Alpha](https://static.seekingalpha.com/uploads/2019/12/14/3028641-1576365091899037_origin.png)
Pfizer: New CEO, New Strategy, New Focus On Brand Name Drugs In A Year Of Drastic Change (NYSE:PFE) | Seeking Alpha
![Pfizer's COVID-19 shot is 2021's best seller, $16B ahead of AbbVie's Humira | S&P Global Market Intelligence Pfizer's COVID-19 shot is 2021's best seller, $16B ahead of AbbVie's Humira | S&P Global Market Intelligence](https://www.snl.com/articles/411722648.png)
Pfizer's COVID-19 shot is 2021's best seller, $16B ahead of AbbVie's Humira | S&P Global Market Intelligence
![Pfizer expects historic $54B in sales from COVID-19 vaccine, pill in 2022 | S&P Global Market Intelligence Pfizer expects historic $54B in sales from COVID-19 vaccine, pill in 2022 | S&P Global Market Intelligence](https://www.snl.com/articles/411327690.png)
Pfizer expects historic $54B in sales from COVID-19 vaccine, pill in 2022 | S&P Global Market Intelligence
MedicinMan - Enabling Digital Adoption in Healthcare - Sanofi, GSK, Novartis, Merck & Pfizer - Leaders in EML .................................................................... The top 20 pharmaceutical companies collectively submitted 778 medicines ...
![Leading Consumer Healthcare Products - Pfizer 2014 Annual Review | Pfizer: the world's largest research-based pharmaceutical company Leading Consumer Healthcare Products - Pfizer 2014 Annual Review | Pfizer: the world's largest research-based pharmaceutical company](https://www.pfizer.com/sites/default/files/investors/financial_reports/annual_reports/2014/assets/images/science/products/advil-1.jpg)